# Immunogenicity Study of the Japanese Encephalitis Vaccine IC51

> **NCT00604708** · PHASE3 · COMPLETED · sponsor: **Valneva Austria GmbH** · enrollment: 867 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** IC51
- **BIOLOGICAL:** JE-VAX

## Key facts

- **NCT ID:** NCT00604708
- **Lead sponsor:** Valneva Austria GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 867 (ACTUAL)
- **Last updated:** 2024-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00604708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00604708, "Immunogenicity Study of the Japanese Encephalitis Vaccine IC51". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00604708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*